These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 4527847)
1. Induction of remission with l-Asparaginase, cyclophosphamide, cytosine arabinoside, and prednisolone in adult patients with acute leukemia. Gahrton G; Engstedt L; Franzén S; Gullbring B; Holm G; Höglund S; Killander A; Killander D; Lockner D; Mellstedt H; Palmblad J; Reizenstein P; Skarberg KO; Swedberg B; Udén AM Cancer; 1974 Aug; 34(2):472-9. PubMed ID: 4527847 [No Abstract] [Full Text] [Related]
2. Combination chemotherapy for children with acute lymphocytic leukemia who fail to respond to standard remission-induction therapy. Lay HN; Ekert H; Colebatch JH Cancer; 1975 Oct; 36(4):1220-2. PubMed ID: 1058044 [TBL] [Abstract][Full Text] [Related]
3. L-asparaginase and prednisolone pretreatment followed by rubidomycin and cytosine arabinoside for induction of remission in adult patients with acute myeloblastic leukaemia. Udén AM; Brenning G; Engstedt L; Franzén S; Gahrton G; Gullbring B; Holm G; Höglund S; Jameson S; Killander A; Killander D; Lockner D; Mellstedt H; Palmblad J; Reizenstein P; Skårberg KO; Swedberg B; Wadman B; Wide L Scand J Haematol; 1975 Aug; 15(1):72-80. PubMed ID: 1058527 [TBL] [Abstract][Full Text] [Related]
4. Short courses of cytosine arabinoside and L-asparaginase in children with acute leukemia. Ekert H; Colebatch JH; Matthews RN Cancer; 1972 Sep; 30(3):643-7. PubMed ID: 4507080 [No Abstract] [Full Text] [Related]
5. Refractory leukemia treated with cytosine arabinoside and cyclophosphamide. Ansari BM; Thompson EN Cancer; 1973 Aug; 32(2):294-7. PubMed ID: 4516215 [No Abstract] [Full Text] [Related]
6. Combination chemotherapy using L-asparaginase, daunorubicin, and cytosine arabinoside in adults with acute myelogenous leukaemia. Crowther D; Bateman CJ; Vartan CP; Whitehouse JM; Malpas JS; Fairley GH; Scott RB Br Med J; 1970 Nov; 4(5734):513-7. PubMed ID: 4921703 [TBL] [Abstract][Full Text] [Related]
7. Use of L-asparaginase and cytosine arabinoside for refractory acute lymphocytic leukemia with particular reference to T-cell leukemia. Steuber CP; Levy GJ; Nix WL; Shepherd DA; Starling KA; Fernbach DJ Med Pediatr Oncol; 1978; 5(1):33-8. PubMed ID: 311413 [TBL] [Abstract][Full Text] [Related]
8. Therapy of acute leukemia with drug combinations which include asparaginase. Leventhal BG; Henderson ES Cancer; 1971 Oct; 28(4):825-9. PubMed ID: 5286445 [No Abstract] [Full Text] [Related]
9. [Sequential combination of high-dose cytosine arabinoside and L-asparaginase in the treatment of refractory acute leukemia and malignant lymphoma]. Shimazaki C; Fujita N; Nakanishi S; Nishio A; Haruyama H; Nakagawa M; Ijichi H Gan To Kagaku Ryoho; 1985 Nov; 12(11):2202-7. PubMed ID: 3864396 [TBL] [Abstract][Full Text] [Related]
10. L-asparaginase used with cytosine arabinoside in treatment of childhood acute lymphocytic leukemia refractory to vincristine and prednisone. Smithson WA; Gilchrist GS; Burgert EO Med Pediatr Oncol; 1979; 6(2):163-70. PubMed ID: 287856 [TBL] [Abstract][Full Text] [Related]
11. [Therapy of acute leukemia. 4. Remission induction and remission maintenance therapy]. Hirano M; Uetani T; Morita A; Sako F; Koie K Saishin Igaku; 1971 Oct; 26(10):2034-41. PubMed ID: 5288692 [No Abstract] [Full Text] [Related]